<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10804688</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Nos, P</dc:author>
<dc:author>Ortiz, V</dc:author>
<dc:author>Berenguer, J</dc:author>
<dc:author>Aguilera, V</dc:author>
<dc:author>Ponce, J</dc:author>
<dc:description xml:lang="en">AIM To assess the efficacy of oral microemulsion cyclosporin as the initial treatment of active ulcerative colitis refractory to steroid therapy. PATIENTS AND METHODS The evolution of five patients treated with a dose of 5 mg/kg/day was analyzed. RESULTS Oral microemulsion cyclosporin controlled acute attacks of the disease and led to remission during the 3 months of treatment in four of the five patients. Average hospital stay was 5.5 days. CONCLUSIONS Oral microemulsion cyclosporin is an effective treatment in ulcerative colitis. Its administration is simple, the use of venous catheters is avoided and it may reduce mean hospital stay.</dc:description>
<dc:type>Clinical Trial</dc:type>
<dc:language>es</dc:language>
<dc:date>2000 Mar </dc:date>
<dc:title xml:lang="es">Ciclosporina en microemulsi√≥n oral como tratamiento inicial de la colitis ulcerosa activa corticorrefractaria.</dc:title>
<dc:title xml:lang="en">[Cyclosporin in an oral microemulsion as the initial treatment of corticoid-refractory ulcerative colitis].</dc:title>
<dc:publisher>Gastroenterologia y hepatologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
